Stanley-Laman Group, Ltd. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$291,000
+12.8%
27,0590.0%0.07%
+11.1%
Q1 2019$258,000
-83.1%
27,059
-74.8%
0.06%
-81.6%
Q2 2018$1,527,000107,5480.34%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,400,000$12,320,0004.56%
EcoR1 Capital, LLC 2,568,119$22,599,0004.01%
FIC CAPITAL INC 960,338$8,451,0003.48%
Opaleye Management Inc. 580,000$5,104,0002.13%
DAFNA Capital Management LLC 225,000$1,980,0001.41%
RA Capital Management 1,250,000$11,000,0001.26%
Iguana Healthcare Management, LLC 215,000$1,892,0001.07%
Avoro Capital Advisors LLC 800,000$7,040,0000.89%
WASATCH ADVISORS LP 6,930,535$60,989,0000.85%
Cormorant Asset Management, LP 400,000$3,520,0000.58%
View complete list of SANGAMO THERAPEUTICS INC shareholders